| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1051061385 |
| P356 | DOI | 10.1038/NPP.2011.19 |
| P932 | PMC publication ID | 3096804 |
| P698 | PubMed publication ID | 21412227 |
| P5875 | ResearchGate publication ID | 50409781 |
| P50 | author | Iain McGregor | Q56947672 |
| Brian Oldfield | Q68259849 | ||
| P2093 | author name string | Aneta Stefanidis | |
| Aaron N A Verty | |||
| Geraldine J Crouch | |||
| Megan J Evetts | |||
| P2860 | cites work | The role of thermogenesis in antipsychotic drug-induced weight gain. | Q46184209 |
| The effects of rimonabant on brown adipose tissue in rat: implications for energy expenditure. | Q46213429 | ||
| Elevated cannabinoid 1 receptor mRNA is linked to eating disorder related behavior and attitudes in females with eating disorders | Q46220744 | ||
| Dopamine antagonism inhibits anorectic behavior in an animal model for anorexia nervosa | Q46270091 | ||
| Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride | Q46371424 | ||
| Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa | Q46446318 | ||
| Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. | Q46495742 | ||
| The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance | Q46595047 | ||
| Paraventricular hypothalamic CB(1) cannabinoid receptors are involved in the feeding stimulatory effects of Delta(9)-tetrahydrocannabinol | Q46649203 | ||
| High-fat diet feeding impairs both the expression and activity of AMPKa in rats' skeletal muscle | Q46826740 | ||
| The appetite suppressant d-fenfluramine reduces water intake, but not food intake, in activity-based anorexia | Q46930806 | ||
| The case for biology in the aetiology of anorexia nervosa | Q47237572 | ||
| Diazepam and body weight in myelopathy patients. | Q47351815 | ||
| Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. | Q47360477 | ||
| Comparison of regional cerebral blood flow in patients with anorexia nervosa before and after weight gain | Q47361319 | ||
| Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol | Q48163060 | ||
| Physical activity and exercise dependence during inpatient treatment of longstanding eating disorders: an exploratory study of excessive and non-excessive exercisers | Q48251561 | ||
| Hunger and satiety in anorexia nervosa: fMRI during cognitive processing of food pictures | Q48434531 | ||
| Increased dopaminergic activity in restricting-type anorexia nervosa. | Q48504402 | ||
| Development of, and recovery from, activity-based anorexia in female rats | Q48570642 | ||
| Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling | Q50113929 | ||
| The use of exposure with response prevention in a male anorexic. | Q50882232 | ||
| Self-starvation of rats living in activity wheels on a restricted feeding schedule | Q51200810 | ||
| Effects of repeated intravenous administration of diazepam on food intake in rats. | Q51646967 | ||
| A double-blind trial of delta 9-tetrahydrocannabinol in primary anorexia nervosa | Q51853691 | ||
| The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic? | Q51980131 | ||
| Leptin Treatment in Activity-Based Anorexia | Q57932176 | ||
| AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats | Q58108110 | ||
| The case for biology in the aetiology of anorexia nervosa1 | Q58425425 | ||
| Role of energy charge and AMP-activated protein kinase in adipocytes in the control of body fat stores | Q60449199 | ||
| The stability of perceptual disturbances in anorexia nervosa | Q66976817 | ||
| Fat aversion in eating disorders | Q67923107 | ||
| Twenty-four-hour food intake in patients with anorexia nervosa and in healthy control subjects | Q72607368 | ||
| Role of the sympathetic nervous system during the development of obesity-induced hypertension in rabbits | Q73824359 | ||
| Abnormal neuronal network in anorexia nervosa studied with I-123-IMP SPECT | Q74265258 | ||
| Eating disorders: progress and problems | Q74594324 | ||
| Neurobiology of anorexia and bulimia nervosa | Q24645913 | ||
| Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study | Q29615905 | ||
| Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study | Q33956807 | ||
| Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward | Q34003324 | ||
| The genetics of anorexia nervosa. | Q34003543 | ||
| Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia | Q34064876 | ||
| Personality variables and disorders in anorexia nervosa and bulimia nervosa | Q34330848 | ||
| Food reward: brain substrates of wanting and liking | Q34378340 | ||
| Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
| Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis | Q34631075 | ||
| Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats | Q35041427 | ||
| Animal models in the investigation of anorexia | Q35159212 | ||
| A high-fat diet prevents and reverses the development of activity-based anorexia in rats | Q35180544 | ||
| Homeostatic and non-homeostatic pathways involved in the control of food intake and energy balance | Q36614334 | ||
| Reward-related responses in the human striatum | Q36754012 | ||
| Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol | Q37087753 | ||
| Endogenous cannabinoids and appetite | Q37352267 | ||
| The effects of acute multiple intraperitoneal injections of the GABAB receptor agonist baclofen on food intake in rats | Q40026349 | ||
| Cannabinoid receptor signaling directly inhibits thermogenesis and alters expression of adiponectin and visfatin | Q40276627 | ||
| Starvation-induced hyperactivity in the rat: the role of endocrine and neurotransmitter changes | Q40619473 | ||
| Eating disorders and hyperactivity: a psychobiological perspective | Q41380362 | ||
| Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine. | Q42154370 | ||
| Olanzapine reduces physical activity in rats exposed to activity-based anorexia: possible implications for treatment of anorexia nervosa? | Q42662354 | ||
| Observational analysis of feeding induced by Delta9-THC and anandamide | Q42677631 | ||
| Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol | Q42981075 | ||
| Activity-based anorexia in C57/BL6 mice: effects of the phytocannabinoid, Delta9-tetrahydrocannabinol (THC) and the anandamide analogue, OMDM-2. | Q43062847 | ||
| Delta(9)-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets | Q43590238 | ||
| Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine | Q43867297 | ||
| Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol | Q44107486 | ||
| Anxiolytic effects of acute tryptophan depletion in anorexia nervosa | Q44375102 | ||
| AICAR stimulates adiponectin and inhibits cytokines in adipose tissue | Q44807015 | ||
| Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development | Q44838499 | ||
| The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol | Q45019379 | ||
| Fenfluramine treatment in female rats accelerates the weight loss associated with activity-based anorexia | Q45243864 | ||
| Dopamine and serotonin release in the nucleus accumbens during starvation-induced hyperactivity. | Q46139551 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cannabinoid receptor | Q421237 |
| cannabinoids | Q422936 | ||
| tetrahydrocannabinol | Q190067 | ||
| CNR2 | Q17907844 | ||
| P304 | page(s) | 1349-1358 | |
| P577 | publication date | 2011-03-16 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia | |
| P478 | volume | 36 |
| Q39285753 | A focus on reward in anorexia nervosa through the lens of the activity-based anorexia (ABA) rodent model |
| Q64983869 | Activity Based Anorexia as an Animal Model for Anorexia Nervosa-A Systematic Review. |
| Q38155986 | Bone health in eating disorders |
| Q38754663 | Cannabinoid CB1 /CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia. |
| Q88009115 | Effect of dronabinol therapy on physical activity in anorexia nervosa: a randomised, controlled trial |
| Q30473707 | Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects |
| Q34495800 | Endocannabinoids and Metabolic Disorders. |
| Q27005662 | Hypothalamic control of brown adipose tissue thermogenesis |
| Q92917437 | Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa |
| Q41152430 | Modulation of food consumption and sleep-wake cycle in mice by the neutral CB1 antagonist ABD459 |
| Q34407191 | Pharmacological manipulations in animal models of anorexia and binge eating in relation to humans. |
| Q39421016 | Polyunsaturated fatty acids and endocannabinoids in health and disease. |
| Q92127450 | Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein-Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with Δ9-Tetrahydrocannabinol and JWH-018 |
| Q36665240 | Sex differences in cannabinoid-regulated biology: A focus on energy homeostasis |
| Q50777328 | Sex-dependent effects of neonatal maternal deprivation on endocannabinoid levels in the adipose tissue: influence of diet. |
| Q50226059 | The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction. |
| Q38891540 | The Role of Mesolimbic Reward Neurocircuitry in Prevention and Rescue of the Activity-Based Anorexia (ABA) Phenotype in Rats |
| Q36918091 | The Role of Psychotropic Medications in the Management of Anorexia Nervosa: Rationale, Evidence and Future Prospects |
| Q48191927 | The effect of dronabinol in a male patient with anorexia nervosa suffering from severe acute urge to be physically active. |
| Q35622131 | The use of animal models to decipher physiological and neurobiological alterations of anorexia nervosa patients |
| Q36408252 | Using the Activity-based Anorexia Rodent Model to Study the Neurobiological Basis of Anorexia Nervosa |
Search more.